Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on L-2-Hydroxyglutaric Aciduria. Data from NIH RePORTER, last 36 months.
L-2-Hydroxyglutaric Aciduria has emerging NIH research funding with 2 grants totaling $206K.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for L-2-Hydroxyglutaric Aciduria. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for L-2-hydroxyglutaric aciduria. Trials may be industry-sponsored or funded through non-NIH sources.
2 funded grants in Basic Science but only 2 related publications found for L-2-hydroxyglutaric aciduria. This may indicate early-stage research that hasn't yet produced published results.
8 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for L-2-hydroxyglutaric aciduria. Existing research activity suggests this may be a viable area for grant applications.
These grants mention L-2-Hydroxyglutaric Aciduria as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.